Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-1166-2014

Drug recall · March 26, 2014

Advil PM Caplets recall

Why: Subpotent Drug: This lot is being recalled because of out-of-specification test results for Diphenhydramine citrate.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Advil PM Caplets, (Ibuprofen, 200 mg /Diphenhydramine citrate, 38 mg) 120 count bottle, OTC, Pfizer, Madison, NJ 07940 USA. NDC 0573-0164-43

Lots / codes

G85041

Quantity
70,704 bottles
Company
Pfizer Us Pharmaceutical Group, New York, NY
Distribution
Nationwide
Initiated
February 26, 2014 · Voluntary: Firm initiated
Classified
March 18, 2014
Reported
March 26, 2014
Ended
July 10, 2015
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Diphenhydramine / ibuprofen

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.